Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study
Top Cited Papers
- 1 July 2000
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 356 (9227), 359-365
- https://doi.org/10.1016/s0140-6736(00)02526-5
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Major Cardiovascular Events in Hypertensive Patients Randomized to Doxazosin vs Chlorthalidone: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Published by American Medical Association (AMA) ,2000
- Dihydropyridine calcium-channel blockers for the treatment of hypertensive diabetic patientsEuropean Heart Journal, 2000
- Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertensionJournal Of Hypertension, 1998
- Meta-analysis. Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double-blind studies until December 1996)Nephrology Dialysis Transplantation, 1998
- Shanghai trial of nifedipine in the elderlyJournal Of Hypertension, 1996
- The Nordic Diltiazem Study (NORDIL). A Prospective Intervention Trial of of Calcium Antagonist Therapy in HypertensionBlood Pressure, 1993
- Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart StudyNew England Journal of Medicine, 1990
- Blood pressure, stroke, and coronary heart disease: Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological contextThe Lancet, 1990
- 1989 Guidelines for the management of mild hypertension: memorandum from a WHO/ISH MeetingJournal of Hypertension, 1989
- Left Ventricular HypertrophyDrugs, 1988